Equinix, Inc. (EQIX) vs National Health Investors, Inc. (NHI)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| EQIX | NHI | |
|---|---|---|
| Sector | Real Estate | Real Estate |
| Industry | REIT - Specialty | REIT - Healthcare Facilities |
| Size band | LARGE | MID |
| Listing | Nasdaq GS | NYSE |
| Country | United States | United States |
| Theme | datacenter-reit | healthcare-reit |
| Price and returns | ||
| Last close | $967.65 | $67.46 |
| Return · 1 week | −0.83% | +4.27% |
| Return · 1 month | −4.29% | +2.37% |
| Return · 3 months | −6.49% | −14.11% |
| Return · year to date | +27.96% | −11.23% |
| Return · 1 year | +16.72% | −8.92% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −14.27% | −26.18% |
| 52-week high | $1,128.68 | $91.38 |
| 52-week low | $720.62 | $63.51 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $94.23B | $3.31B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $484.70M | $22.77M |
| Employees | 13,716 | 32 |
| Valuation | ||
| Price to earnings · trailing | 61.46× | 19.16× |
| Price to earnings · forward | 51.55× | 19.76× |
| Price to sales | 9.51× | 7.47× |
| Price to book | 6.55× | 2.07× |
| Enterprise value to EBITDA | 25.69× | 15.61× |
| Enterprise value to revenue | 11.78× | 10.37× |
| PEG ratio | 2.76 | 4.76 |
| Earnings per share · trailing | 15.54 | 3.46 |
| Profitability | ||
| Gross margin | 51.49% | 97.52% |
| Operating margin | 27.02% | 41.09% |
| Profit margin | 15.48% | 38.21% |
| Return on equity | 10.74% | 10.72% |
| Return on assets | 3.68% | 4.39% |
| Growth | ||
| Revenue growth | +16.70% | +33.80% |
| Earnings growth | +28.80% | +45.20% |
| Balance sheet and payout | ||
| Debt / equity (%) | 162.22 | 80.43 |
| Current ratio | 1.13 | 1.82 |
| Dividend yield | 2.16% | 5.67% |
| Payout ratio | 126.77% | 106.36% |
| Trend and volatility | ||
| RSI · 14 | 39.34 | 53.47 |
| ADX · 14 | 25.30 | 23.86 |
| 50-day average | $1,027.97 | $68.67 |
| 200-day average | $1,006.37 | $76.62 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 3.10% | 2.21% |
The full EQIX analysis
Everything this table leaves out for Equinix, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the EQIX argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full EQIX analysisThe full NHI analysis
Everything this table leaves out for National Health Investors, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the NHI argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full NHI analysis